Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study

The incidence of heart failure hospitalization (HHF) after taking sitagliptin in type 2 diabetes (T2DM) patients with end stage renal disease (ESRD) on dialysis is unclear. In this population-based cohort study, we identified individuals with T2DM and ESRD on dialysis who were treated with sitaglipt...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Yi-Chih, Lin, Che-Chen, Huang, Wei-Lun, Chang, Man-Ping, Chen, Ching-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962317/
https://www.ncbi.nlm.nih.gov/pubmed/27460913
http://dx.doi.org/10.1038/srep30499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962317/
https://www.ncbi.nlm.nih.gov/pubmed/27460913
http://dx.doi.org/10.1038/srep30499

Ejemplares similares